15-Deoxy-Δ12,14-prostaglandin J2 and curcumin modulate the expression of toll-like receptors 4 and 9 in autoimmune T lymphocyte

Journal of Clinical Immunology

Volumn 28, Issue 5, 2008, Pages 558-570

  Chearwae, Wanida ^a   Bright, John J ^a,b  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmune disease; EAE MS; Inflammation; Th1 cell; Toll like receptor

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; CURCUMIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEOLIPID PROTEIN; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ALLERGIC ENCEPHALITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOMODULATION; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWISS JAMES LAMBERT MOUSE; T LYMPHOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CURCUMIN; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FREUND'S ADJUVANT; GLYCOPROTEINS; HUMANS; IMMUNIZATION; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; MYELIN PROTEOLIPID PROTEIN; PEPTIDE FRAGMENTS; PROSTAGLANDIN D2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9;

EID: 51349104881     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-008-9202-7     Document Type: Article

References (76)

1. JH Noseworthy C Lucchinetti M Rodriguez BG Weinshenker 2000 Multiple sclerosis N Engl J Med 343 938 952
2. A Bitsch W Bruck 2002 Differentiation of multiple sclerosis subtypes: implications for treatment CNS Drugs 6 405 418
3. DM Wingerchuk CF Lucchinetti JH Noseworthy 2001 Multiple sclerosis: current pathophysiological concepts Lab Invest 81 263 281
4. L Steinman M Martin C Bernard P Conlon JR Oksenberg 2002 Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy Annu Rev Neurosci 25 491 505
5. RJ Franklin 2002 Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3 705 714
6. MP Coleman VH Perry 2002 Axon pathology in neurological disease: a neglected therapeutic target Trends Neurosci 25 532 537
7. R Gold HP Hartung KV Toyka 2000 Animals model for auto immune demyelinating disorders of the nervous system Mol Med Today 6 88 91
8. JJ Bright S Sriram 2001 Immunotherapy of inflammatory demyelinating diseases of the central nervous system Immunol Res 23 245 252
9. G Muthian JJ Bright 2003 Quercetin ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte J Clin Immunol 24 541 551
10. HP Raikwar G Muthian J Rajasingh C Johnson JJ Bright 2005 PPARg antagonists exacerbate neural antigen-specific Th1 response and experimental allergic encephalomyelitis J Neuroimmunol 167 99 107
11. G Muthian HP Raikwar C Johnson J Rajasingh AS Kalgutkar LJ Marnett JJ Bright 2006 COX-2 inhibitors modulate IL-12 signaling through JAK-STAT pathway leading to Th1 response in experimental allergic encephalomyelitis J Clin Immunol 26 73 85
12. G Muthian HP Raikwar J Rajasingh JJ Bright 2006 1, 25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNg axis leading to Th1 response in experimental allergic encephalomyelitis J Neurosci Res 83 1299 1309
13. RM Evans 1998 The steroid and thyroid hormone receptor superfamily Science 240 889 895
14. B Blumberg RM Evans 1998 Orphan nuclear receptors: new ligands and new possibilities Genes Dev 12 3149 3155
15. R Mukherjee L Jow GE Croston JR Paterniti 1997 Identification, characterization and tissue distribution of human peroxisome proliferator activated receptor isoforms 1 and 2 and activation with retinoid x receptor agonists and antagonists J Biol Chem 272 8071 8076
16. A Elbrecht Y Chen CA Cullinan N Hayes M Leibowitz DE Moller J Berger 1996 Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2 Biochem Biophys Res Commun 224 431 437
17. 2 a ligand for the adipocyte determination factor PPAR gamma Cell 83 803 812
18. JM Lehmann LB Moore TA Smith-Oliver WO Wilkison TM Willson SA Kliewer 1995 An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPARg) J Biol Chem 270 12953 12956
19. M Ricote AC Li TM Willson CJ Kelly CK Glass 1998 The peroxisome proliferator-activated receptor-g is a negative regulator of macrophage activation Nature 391 79 82
20. C Jiang AT Ting B Seed 1998 PPARg agonists inhibit production of monocyte inflammatory cytokine Nature 391 82 86
21. 2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats J Clin Invest 106 189 197
22. BP Neve JC Fruchart B Staels 2000 Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis Biochem Pharmacol 60 1245 1250
23. M Niino K Iwabuchi S Kikuchi M Ato T Morohashi A Ogata K Tashiro K Onoé 2001 Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of PPARg J. Neuroimmunol 116 40 48
24. 2 ameliorates experimental autoimmune encephalomyelitis J Immunol 168 2508 2515
25. C Natarajan JJ Bright 2002 Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation Genes Immun 3 59 70
26. DL Feinstein E Galea V Gavrilyuk CF Brosnan CC Whitacre L Dumitrescu-Ozimek GE Landreth HA Pershadsingh G Weinberg MT Heneka 2002 Peroxisome proliferator activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis Ann Neurol 51 694 702
27. S Schmidt E Moric M Schmidt M Sastre DL Feinstein MT Heneka 2004 Anti-inflammatory and antiproliferative actions of PPAR-gamma agonists on T lymphocytes derived from MS patients J Leukoc Biol 75 478 485
28. C Natarajan G Muthian Y Barak RM Evans JJ Bright 2003 Peroxisome proliferator-activated receptor-gamma deficient heterozygous mice develop an exacerbated neural antigen-induced Th1 response and experimental allergic encephalomyelitis J Immunol 171 5743 5750
29. Y Surh 1999 Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances Mutat Res 428 305 327
30. HP Ammon H Safayhi T Mack J Sabieraj 1993 Mechanism of antiinflammatory actions of curcumine and boswellic acids J Ethnopharmacol 38 113 119
31. RB Arora V Kapoor N Basu AP Jain 1971 Anti-inflammatory studies on Curcuma longa (turmeric) Indian J Med Res 59 1289 1295
32. D Chandra SS Gupta 1972 Anti-inflammatory and anti-arthritic activity of volatile oil of Curcuma longa Indian J Med Res 60 138 142
33. N Ghatak N Basu 1972 Sodium curcuminate as an effective anti-inflammatory agent Indian J Exp Biol 10 235 236
34. A Mukhopadhyay N Basu N Ghatak PK Gujral 1982 Anti-inflammatory and irritant activities of curcumin analogues in rats Agents Actions 12 508 515
35. RC Srimal BN Dhawan 1973 Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent J Pharm Pharmacol 25 447 452
36. C Natarajan JJ Bright 2002 Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes J Immunol 168 6506 6513
37. B Lemaitre E Nicolas L Michaut JM Reichhart JA Hoffmann 1996 The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults Cell 86 973 983
38. KV Anderson 2000 Toll signaling pathways in the innate immune response Curr Opin Immunol 12 13 19
39. RR Schwandner H Dziarski M Wesche CJ Rothe CJ Kirschning 1999 Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2 J Biol Chem 274 17406 17409
40. AO Aliprantis RB Yang MR Mark S Suggett B Devaux JD Radolf GR Klimpel P Godowski A Zychlinsky 1999 Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2 Science 285 736 739
41. L Alexopoulou AC Holt R Medzhitov A Flavell 2001 Recognition of double-stranded RNA and activation of NF-kB by Toll-like receptor 3 Nature 413 732 738
42. A Poltorak X He I Smirnova MY Liu C Van Huffel X Du D Birdwell E Alejos M Silva C Galanos M Freudenberg P Ricciardi-Castagnoli B Layton B Beutler 1998 Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene Science 282 2085 2088
43. F Hayashi KD Smith A Ozinsky TR Hawn EC Yi DR Goodlett JK Eng S Akira DM Underhill A Aderem 2001 The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 Nature 410 1099 1103
44. H Hemmi T Kaisho O Takeuchi S Sato H Sanjo K Hoshino T Horiuchi H Tomizawa K Takeda S Akira 2002 Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway Nat Immunol 3 196 200
45. M Jurk F Heil J Vollmer C Schetter AM Krieg H Wagner G Lipford S Bauer 2002 Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 Nat Immunol 3 196 200
46. F Heil H Hemmi H Hochrein F Ampenberger C Kirschning S Akira G Lipford H Wagner S Bauer 2004 Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8 Science 303 1526 1529
47. SS Diebold T Kaisho H Hemmi S Akira CR Sousa 2004 Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA Science 303 1529 1531
48. HO Hemmi T Takeuchi T Kawai S Kaisho Sato H Sanjo M Matsumoto K Hoshino H Wagner K Takeda S Akira 2000 A Toll-like receptor recognizes bacterial DNA Nature 408 740 745
49. DM Underhill 2003 Toll-like receptors: networking for success Eur J Immunol 33 1767 1775
50. GM Barton R Medzhitov 2003 Toll-like receptor signaling pathways Science 300 1524 1525
51. R Medzhitov P Preston-Hurlburt E Kopp A Stadlen C Chen S Ghosh Jr CA Janeway 1998 MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways Mol Cell 2 253 258
52. M Muzio J Ni P Feng VM Dixit 1997 IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling Science 278 1612 1615
53. T Kawai O Adachi T Ogawa K Takeda S Akira 1997 Unresponsiveness of MyD88-deficient mice to endotoxin Immunity 11 115 122
54. O Adachi T Kawai K Takeda M Matsumoto H Tsutsui M Sakagami K Nakanishi S Akira 1998 Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function Immunity 9 143 150
55. O Takeuchi K Takeda K Hoshino O Adachi T Ogawa S Akira 2000 Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades Int Immunol 2 113 117
56. H Häcker RM Vabulas O Takeuchi K Hoshino S Akira H Wagner 2000 Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF) 6 J Exp Med 192 595 600
57. V Hornung S Rothenfusser S Britsch A Krug B Jahrsdorfer T Giese S Endres G Hartmann 2002 Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides J Immunol 168 4531 4537
58. KA Zarember PJ Godowski 2002 Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines J Immunol 168 554 561
59. T Kaisho S Akira 2001 Dendritic cell function in Toll-like receptor and MyD88 knockout mice Trends Immunol 22 78 83
60. M Bsibsi R Ravid D Gveric JM van Noort 2002 Broad expression of Toll-like receptors in the human central nervous system J Neuropathol Exp Neurol 61 1013 1021
61. H Zekki DL Feinstein S Rivest 2002 The clinical course of experimental autoimmune encephalomyelitis is associated with a profound and sustained transcriptional activation of the genes encoding toll-like receptor 2 and CD14 in the mouse CNS Brain Pathol 12 308 319
62. SM Kerfoot EM Long MJ Hickey G Andonegui GB Lapointe RC Zanardo C Bonder WG James SM Robbins P Kubes 2004 TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease J Immunol 173 7070 7077
63. MK Racke W Hu AE Lovett-Racke 2005 PTX cruiser: driving autoimmunity via TLR4 Trends Immunol 26 289 291
64. BS Hansen RZ Hussain AE Lovett-Racke JA Thomas MK Racke 2006 Multiple toll-like receptor agonists act as potent adjuvants in the induction of autoimmunity J Neuroimmunol 172 94 103
65. M Prinz F Garbe H Schmidt A Mildner I Gutcher K Wolter M Piesche R Schroers E Weiss CJ Kirschning CD Rochford W Bruck B Becher 2006 Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis J Clin Invest 116 456 464
66. NA Wolf TK Amouzegar RH Swanborg 2007 Synergistic interaction between Toll-like receptor agonists is required for induction of experimental autoimmune encephalomyelitis in Lewis rats J Neuroimmunol 185 115 122
67. M Komai-Koma L Jones GS Ogg D Xu FY Liew 2004 TLR2 is expressed on activated T cells as a costimulatory receptor Proc Natl Acad Sci U S A 101 3029 3034
68. + T cells J Immunol 175 1551 1557
69. T Touil D Fitzgerald GX Zhang A Rostami B Gran 2006 TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta J Immunol 177 7505 7509
70. S Ogawa J Lozach C Benner G Pascual RK Tangirala S Westin A Hoffmann S Subramaniam M David MG Rosenfeld CK Glass 2005 Molecular determinants of cross-talk between nuclear receptors and toll-like receptors Cell 122 707 721
71. S Appel V Mirakaj A Bringmann MM Weck F Grunebach P Brossart 2005 PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways Blood 106 3888 3894
72. NK Phulwani DL Feinstein V Gavrilyuk C Akar T Kielian 2006 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway J Neurochem 99 1389 1402
73. P Chowdhury SH Sacks NS Sheerin 2006 Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products Clin Exp Immunol 145 346 356
74. HS Youn SI Saitoh K Miyake DH Hwang 2006 Inhibition of homodimerization of Toll-like receptor 4 by curcumin Biochem Pharmacol 72 62 69
75. S Kato Y Yuzawa N Tsuboi S Maruyama Y Morita T Matsuguchi S Matsuo 2004 Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4 J Am Soc Nephrol 15 1289 1299
76. CS Eun DS Han SH Lee CH Paik YW Chung J Lee JS Hahm 2006 Attenuation of colonic inflammation by PPARg in intestinal epithelial cells: effect on Toll-like receptor pathway Dig Dis Sci 51 693 697